{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:49:22Z","timestamp":1782960562701,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s00428-025-04070-0","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T08:46:31Z","timestamp":1741855591000},"page":"839-851","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["EGFR mutations in sinonasal squamous neoplasms: Novel hotspot for exon 20 insertions"],"prefix":"10.1007","volume":"487","author":[{"given":"Kirti","family":"Srivastava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavneet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitesh","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepali","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alok","family":"Thakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4303-1099","authenticated-orcid":false,"given":"Aanchal","family":"Kakkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"key":"4070_CR1","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.3390\/cancers14061463","volume":"14","author":"C Taverna","year":"2022","unstructured":"Taverna C, Agaimy A, Franchi A (2022) Towards a molecular classification of sinonasal carcinomas: clinical implications and opportunities. Cancers 14:1463","journal-title":"Cancers"},{"key":"4070_CR2","first-page":"368","volume":"58","author":"VN Cabal","year":"2020","unstructured":"Cabal VN, Menendez M, Vivanco B et al (2020) EGFR mutation and HPV infection in sinonasal inverted papilloma and squamous cell carcinoma. Rhinology 58:368\u2013376","journal-title":"Rhinology"},{"key":"4070_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s12105-016-0692-y","volume":"10","author":"JS Lewis Jr","year":"2016","unstructured":"Lewis JS Jr (2016) Sinonasal squamous cell carcinoma: a review with emphasis on emerging histologic subtypes and the role of human papillomavirus. Head Neck Pathol 10:60\u201367","journal-title":"Head Neck Pathol"},{"key":"4070_CR4","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.3390\/cancers13163995","volume":"13","author":"F Chatelet","year":"2021","unstructured":"Chatelet F, Simon F, Bedarida V et al (2021) Surgical management of sinonasal cancers: A Comprehensive Review. Cancers (Basel) 13:3995","journal-title":"Cancers (Basel)"},{"key":"4070_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s12105-008-0048-3","volume":"2","author":"W Lawson","year":"2008","unstructured":"Lawson W, Schlecht NF, Brandwein-Gensler M (2008) The role of the human papillomavirus in the pathogenesis of Schneiderian inverted papillomas: an analytic overview of the evidence. Head Neck Pathol 2:49\u201359","journal-title":"Head Neck Pathol"},{"key":"4070_CR6","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1097\/PAS.0b013e318254ce54","volume":"36","author":"JA Bishop","year":"2012","unstructured":"Bishop JA, Westra WH (2012) NUT midline carcinomas of the sinonasal tract. Am J Surg Pathol 36:1216\u20131221","journal-title":"Am J Surg Pathol"},{"key":"4070_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/PAS.0b013e3182698673","volume":"37","author":"JA Bishop","year":"2013","unstructured":"Bishop JA, Guo TW, Smith DF et al (2013) Human papillomavirus-related carcinomas of the sinonasal tract. Am J Surg Pathol 37:185\u2013192","journal-title":"Am J Surg Pathol"},{"key":"4070_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s12105-013-0514-4","volume":"8","author":"JS Lewis Jr","year":"2014","unstructured":"Lewis JS Jr, Westra WH, Thompson LD et al (2014) The sinonasal tract: another potential \u2018\u201cHot Spot\u201d\u2019 for carcinomas with transcriptionally-active human papillomavirus. Head Neck Pathol 8:241\u2013249","journal-title":"Head Neck Pathol"},{"key":"4070_CR9","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/modpathol.2013.155","volume":"27","author":"AB Larque","year":"2014","unstructured":"Larque AB, Hakim S, Ordi J et al (2014) High-risk human papillomavirus is transcriptionally active in a subset of sinonasal squamous cell carcinomas. Mod Pathol 27:343\u2013351","journal-title":"Mod Pathol"},{"key":"4070_CR10","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s12105-017-0858-2","volume":"12","author":"A Kakkar","year":"2018","unstructured":"Kakkar A, Antony VM, Irugu DVK, Adhikari N, Jain D (2018) NUT midline carcinoma: a series of five cases, including one with unusual clinical course. Head Neck Pathol 12:230\u2013236","journal-title":"Head Neck Pathol"},{"key":"4070_CR11","doi-asserted-by":"crossref","unstructured":"Rooper LM, Agaimy A, Dickson BC et al (2021) DEK-AFF2 carcinoma of the sinonasal region and skull base: detailed clinicopathologic characterization of a distinctive entity. Am J Surg Pathol 45:1682\u201393","DOI":"10.1097\/PAS.0000000000001741"},{"key":"4070_CR12","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00428-023-03601-x","volume":"483","author":"A Kakkar","year":"2023","unstructured":"Kakkar A, Satapathy S, Sikka K, Tanwar P, Deo S, Jain D (2023) Evaluation of high-risk human papillomavirus in sinonasal papillomas and squamous cell carcinomas. Virchows Arch 483:381\u2013392","journal-title":"Virchows Arch"},{"key":"4070_CR13","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3390\/cancers14020394","volume":"14","author":"L Pacini","year":"2022","unstructured":"Pacini L, Cabal VN, Hermsen MA, Huang PH (2022) EGFR exon 20 insertion mutations in sinonasal squamous cell carcinoma. Cancers (Basel) 14:394","journal-title":"Cancers (Basel)"},{"key":"4070_CR14","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.3390\/cancers14092195","volume":"14","author":"JG Eide","year":"2022","unstructured":"Eide JG, Welch KC, Adappa ND, Palmer JN, Tong CCL (2022) Sinonasal inverted papilloma and squamous cell carcinoma: contemporary management and patient outcomes. Cancers (Basel) 14:2195","journal-title":"Cancers (Basel)"},{"issue":"13","key":"4070_CR15","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1158\/0008-5472.CAN-15-0340","volume":"75","author":"AM Udager","year":"2015","unstructured":"Udager AM, Udager AM, Rolland DCM, McHugh JB et al (2015) High-frequency targetable EGFR mutations in sinonasal squamous cell carcinomas arising from inverted sinonasal papilloma. Cancer Res 75(13):2600\u20132606","journal-title":"Cancer Res"},{"key":"4070_CR16","doi-asserted-by":"publisher","first-page":"908","DOI":"10.18632\/oncoscience.268","volume":"2","author":"JB McHugh","year":"2015","unstructured":"McHugh JB, Elenitoba-Johnson KS, Brown NA (2015) EGFR mutations in sinonasal squamous tumors: oncogenic and therapeutic implications. Oncoscience 2:908\u2013909","journal-title":"Oncoscience"},{"key":"4070_CR17","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/ijc.31971","volume":"144","author":"N Sahnane","year":"2019","unstructured":"Sahnane N, Ottini G, Turri-Zanoni M et al (2019) Comprehensive analysis of HPV infection, EGFR exon 20 mutations and LINE1 hypomethylation as risk factors for malignant transformation of sinonasal-inverted papilloma to squamous cell carcinoma. Int J Cancer 144:1313\u20131320","journal-title":"Int J Cancer"},{"key":"4070_CR18","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/PAS.0000000000001411","volume":"44","author":"M Mehrad","year":"2020","unstructured":"Mehrad M, Stelow EB, Bishop JA et al (2020) Transcriptionally active HPV and targetable EGFR mutations in sinonasal inverted papilloma: an association between low-risk HPV, condylomatous morphology, and cancer risk? Am J Surg Pathol 44:340\u2013346","journal-title":"Am J Surg Pathol"},{"key":"4070_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2020.151504","volume":"46","author":"S Maisch","year":"2020","unstructured":"Maisch S, Mueller SK, Traxdorf M et al (2020) Sinonasal papillomas: a single centre experience on 137 cases with emphasis on malignant transformation and EGFR\/KRAS status in \u201ccarcinoma ex papilloma.\u201d Ann Diagn Pathol 46:151504","journal-title":"Ann Diagn Pathol"},{"key":"4070_CR20","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1093\/annonc\/mdx736","volume":"29","author":"AM Udager","year":"2018","unstructured":"Udager AM, McHugh JB, Goudsmit CM et al (2018) Human papillomavirus (HPV) and somatic EGFR mutations are essential, mutually exclusive oncogenic mechanisms for inverted sinonasal papillomas and associated sinonasal squamous cell carcinomas. Ann Oncol 29:466\u2013471","journal-title":"Ann Oncol"},{"key":"4070_CR21","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/hed.23317","volume":"36","author":"A Bahl","year":"2014","unstructured":"Bahl A, Kumar P, Dar L et al (2014) Prevalence and trends of human papillomavirus in oropharyngeal cancer in a predominantly north Indian population. Head Neck 36:505\u2013510","journal-title":"Head Neck"},{"key":"4070_CR22","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/PAS.0000000000001566","volume":"45","author":"T Hongo","year":"2021","unstructured":"Hongo T, Yamamoto H, Jiromaru R et al (2021) Clinicopathologic significance of EGFR mutation and HPV infection in sinonasal squamous cell carcinoma. Am J Surg Pathol 45:108\u2013118","journal-title":"Am J Surg Pathol"},{"key":"4070_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.lungcan.2020.07.038","volume":"149","author":"V Singh","year":"2020","unstructured":"Singh V, Nambirajan A, Malik PS et al (2020) Spectrum of uncommon and compound epidermal growth factor receptor mutations in non-small-cell lung carcinomas with treatment response and outcome analysis: a study from India. Lung Cancer 149:53\u201360","journal-title":"Lung Cancer"},{"key":"4070_CR24","doi-asserted-by":"publisher","first-page":"559","DOI":"10.5858\/arpa.2017-0286-CP","volume":"142","author":"JS Lewis Jr","year":"2018","unstructured":"Lewis JS Jr et al (2018) Human papillomavirus testing in head and neck carcinomas: guideline from the College of American Pathologists. Arch Pathol Lab Med 142:559\u2013597","journal-title":"Arch Pathol Lab Med"},{"key":"4070_CR25","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s12105-023-01582-6","volume":"17","author":"A Kakkar","year":"2023","unstructured":"Kakkar A, Srivastava K, Deepa S et al (2023) HPV-associated squamous cell carcinoma of the eyelid: diagnostic utility of p16 immunohistochemistry and mRNA in situ hybridization. Head Neck Pathol 17:889\u2013898","journal-title":"Head Neck Pathol"},{"key":"4070_CR26","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1111\/his.13732","volume":"73","author":"E Sasaki","year":"2018","unstructured":"Sasaki E, Nishikawa D, Hanai N, Hasegawa Y, Yatabe Y (2018) Sinonasal squamous cell carcinoma and EGFR mutations: a molecular footprint of a benign lesion. Histopathology 73:953\u2013962","journal-title":"Histopathology"},{"key":"4070_CR27","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s10147-018-1296-1","volume":"23","author":"S Yasukawa","year":"2018","unstructured":"Yasukawa S, Kano S, Hatakeyama H et al (2018) Genetic mutation analysis of the malignant transformation of sinonasal inverted papilloma by targeted amplicon sequencing. Int J Clin Oncol 23:835\u2013843","journal-title":"Int J Clin Oncol"},{"key":"4070_CR28","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/his.13868","volume":"75","author":"H Wang","year":"2019","unstructured":"Wang H, Li H, Hu L, Zhou J, Zhai C, Wang D, Sun X (2019) EGFR and KRAS mutations in Chinese patients with sinonasal inverted papilloma and oncocytic papilloma. Histopathology 75:274\u2013281","journal-title":"Histopathology"},{"key":"4070_CR29","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.jcms.2021.02.016","volume":"49","author":"D Nishikawa","year":"2021","unstructured":"Nishikawa D, Sasaki E, Suzuki H et al (2021) Treatment outcome and pattern of recurrence of sinonasal squamous cell carcinoma with EGFR-mutation and human papillomavirus. J Craniomaxillofac Surg 49:494\u2013500","journal-title":"J Craniomaxillofac Surg"},{"key":"4070_CR30","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/s41379-020-00716-3","volume":"34","author":"NA Brown","year":"2021","unstructured":"Brown NA, Plouffe KR, Yilmaz O et al (2021) TP53 mutations and CDKN2A mutations\/deletions are highly recurrent molecular alterations in the malignant progression of sinonasal papillomas. Mod Pathol 34:1133\u20131142","journal-title":"Mod Pathol"},{"key":"4070_CR31","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s00428-020-02945-y","volume":"478","author":"S Zonnur","year":"2021","unstructured":"Zonnur S, Erbersdobler A, Schneider B (2021) EGFR and BRAF mutations in inverted sinonasal papilloma - a more complex landscape? Virchows Arch 478:915\u2013924","journal-title":"Virchows Arch"},{"key":"4070_CR32","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.21037\/tcr.2020.03.10","volume":"9","author":"F Wang","year":"2020","unstructured":"Wang F, Li C, Wu Q, Lu H (2020) EGFR exon 20 insertion mutations in non-small cell lung cancer. Transl Cancer Res 9:2982\u20132991","journal-title":"Transl Cancer Res"},{"key":"4070_CR33","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1016\/S1470-2045(11)70129-2","volume":"13","author":"H Yasuda","year":"2012","unstructured":"Yasuda H, Kobayashi S, Costa DB (2012) EGFR exon 20 insertion mutations in non-small-cell lung cancer: preclinical data and clinical implications. Lancet Oncol 13:e23\u2013e31","journal-title":"Lancet Oncol"},{"key":"4070_CR34","doi-asserted-by":"publisher","first-page":"e36667","DOI":"10.1097\/MD.0000000000036667","volume":"102","author":"H Han","year":"2023","unstructured":"Han H, Zhang X, Liu X et al (2023) First report of furmonertinib as a first-line treatment in advanced lung adenocarcinoma patients harboring EGFR exon 20 insertion mutations after the kinase domain \u03b1C-helix: Two case reports and a literature review. Medicine (Baltimore) 102:e36667","journal-title":"Medicine (Baltimore)"},{"key":"4070_CR35","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1111\/1759-7714.15127","volume":"14","author":"B Pan","year":"2023","unstructured":"Pan B, Liang J, Shi H, Rao K, Guo W, Zhan C (2023) Epidemiological characteristics and therapeutic advances of EGFR exon 20 insertion mutations in non-small cell lung cancer. Thorac Cancer 14:3247\u20133258","journal-title":"Thorac Cancer"},{"key":"4070_CR36","doi-asserted-by":"publisher","first-page":"238","DOI":"10.21037\/tlcr-22-48","volume":"11","author":"Y Chen","year":"2022","unstructured":"Chen Y, Xu J, Zhang L et al (2022) A multicenter-retrospective study of non-small-cell lung carcinoma harboring uncommon epidermal growth factor receptor (EGFR) mutations: different subtypes of EGFR exon 19 deletion-insertions exhibit the clinical characteristics and prognosis of non-small cell lung carcinoma. Transl Lung Cancer Res 11:238\u2013249","journal-title":"Transl Lung Cancer Res"},{"key":"4070_CR37","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1097\/JTO.0b013e318290868f","volume":"8","author":"NI Lindeman","year":"2013","unstructured":"Lindeman NI, Cagle PT, Beasley MB et al (2013) Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors. J Thorac Oncol 8:823\u2013859","journal-title":"J Thorac Oncol"},{"key":"4070_CR38","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1038\/modpathol.3801018","volume":"21","author":"M Ladanyi","year":"2008","unstructured":"Ladanyi M, Pao W (2008) Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond. Mod Pathol 21:S16\u2013S22","journal-title":"Mod Pathol"},{"key":"4070_CR39","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jtho.2017.12.001","volume":"13","author":"NI Lindeman","year":"2018","unstructured":"Lindeman NI, Cagle PT, Aisner DL et al (2018) Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors. J Thorac Oncol 13:323\u2013358","journal-title":"J Thorac Oncol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04070-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-025-04070-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04070-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T02:55:22Z","timestamp":1761188122000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-025-04070-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["4070"],"URL":"https:\/\/doi.org\/10.1007\/s00428-025-04070-0","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"19 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was obtained from the Institute Ethics committee for conducting this study (IEC-545\/02.08.2019).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors have no competing interests to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}